Jason McKeown

Driven by his combined passion for improving people’s lives, neuroscience and technology Jason has transitioned from being a medical doctor in the UK to founding Neurovalens.

Jason also holds an academic position at the University California, San Diego (UCSD), where he researches neuroscience and neuromodulation in partnership with distinguished Professor VS. Ramachandran.

Jason’s current focus is on the type 2 diabetes, with the primary goal being the creation of the worlds first FDA approved non-invasive treatment.

Over the coming years, Jason will be focused on continuing to transform lives by bringing new neuro-technology solutions to market to help improve the lives of those who suffer from both metabolic and neurological issues.